Associate Professor
Dr. Doan is the Director of the Ralph and Sophie Heintz Laboratory. Her current research uses genomic technologies to identify and characterize infectious and autoimmune causes of uveitis. She collaborates with Dr. Lietman to study how the various human microbiomes (ocular, gut, and upper respiratory tract) respond to clinically relevant perturbations in randomized controlled trials.
For more Dr. Doan's research details please visit: Doan Lab at UCSF
Education:
- University of Washington, Medical Scientist Training Program, Ph.D.
- Marine Biological Laboratory, Woods Hole, Neurobiology, Summer Course
- Stanford University, M.D.
- Santa Clara Valley Medical Center, Intern, Preliminary Medicine
- University of Washington, Resident, Ophthalmology
- University of Washington, Fellow, Uveitis
For more details please visit: https://profiles.ucsf.edu/thuy.doan
ACTION was a research study to determine if taking a medication called azithromycin can help treat COVID-19 disease.
This randomized controlled trial evaluates the effect of topical antibiotics on the local ocular surface resistome and microbiome and other systemic sites including the nasopharynx, mouth, and gut.
Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the CORNea (CapriCORN)
These large randomized controlled trials evaluate the effect of mass drug distribution to improve childhood mortality in Niger and Burkina Faso.
This multi-site randomized controlled trial is designed to compare metagenomic deep sequencing (MDS) versus standard of care testing for improvement of outcomes for intraocular infections.
We work to optimize deep sequencing approaches to help improve diagnostics of ocular infections for clinicians and patients.
The Proctor Foundation was founded in 1947 with the aim of trachoma eradication. The laboratory works closely with Proctor faculty members to design, optimize, and implement molecular assays to improve surveillance and treatment paradigms.
SCORPIO is an international, multi-site study that takes advantage of advances in genomic technologies to enhance our understanding of conjunctivitis epidemics globally by identifying the pathogens involved, characterizing the evolution of pathogen genomes across time and space, and defining the immune responses to these infections.
Funded by:
Work from the Doan Lab would not have been possible without generous support.
To learn more about Dr. Doan's Research Please visit https://doanlab.ucsf.edu/research